Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
作者： John J. Chen , Elliott H. Sohn , James C. Folk , Vinit B. Mahajan , Christine N. Kay
DOI: 10.1097/IAE.0000000000000093
关键词: Idiopathic juxtafoveal telangiectasia 、 In patient 、 Macular telangiectasia 、 Ophthalmology 、 Methazolamide 、 Acetazolamide 、 Carbonic anhydrase 、 Retrospective review 、 Medicine
摘要: Purpose:To evaluate whether carbonic anhydrase inhibitors reduce the macular thickness and/or cystic spaces in patients with telangiectasia (MacTel) Type 2.Methods:Retrospective review of nonproliferative cystoid changes associated MacTel seen at University Iowa bet
elsevier.com
sci-hub.se 参考文章(22)
Thomas J. Wolfensberger, The role of carbonic anhydrase inhibitors in the management of macular edema. Documenta Ophthalmologica. ,vol. 97, pp. 387- 397 ,(1999) , 10.1007/978-94-011-4152-9_22
Ute E. K. Wolf-Schnurrbusch, Lala Ceklic, Christian K. Brinkmann, Milko E. Iliev, Manuel Frey, Simon P. Rothenbuehler, Volker Enzmann, Sebastian Wolf, Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology & Visual Science. ,vol. 50, pp. 3432- 3437 ,(2009) , 10.1167/IOVS.08-2970
P. Bhattacherjee, Distribution of carbonic anhydrase in the rabbit eye as demonstrated histochemically. Experimental Eye Research. ,vol. 12, pp. 356- 359 ,(1971) , 10.1016/0014-4835(71)90160-6
Mohamed A. Genead, Efficacy of Sustained Topical Dorzolamide Therapy for Cystic Macular Lesions in Patients With Retinitis Pigmentosa and Usher Syndrome Archives of Ophthalmology. ,vol. 128, pp. 1146- 1150 ,(2010) , 10.1001/ARCHOPHTHALMOL.2010.172
Mohamed A. Genead, Efficacy of Sustained Topical Dorzolamide Therapy for Cystic Macular Lesions in Patients With X-Linked Retinoschisis Archives of Ophthalmology. ,vol. 128, pp. 190- 197 ,(2010) , 10.1001/ARCHOPHTHALMOL.2009.398
Michael B. Powner, Mark C. Gillies, Marina Tretiach, Andrew Scott, Robyn H. Guymer, Gregory S. Hageman, Marcus Fruttiger, Perifoveal Müller Cell Depletion in a Case of Macular Telangiectasia Type 2 Ophthalmology. ,vol. 117, pp. 2407- 2416 ,(2010) , 10.1016/J.OPHTHA.2010.04.001
ROBERT C. WATZKE, MICHAEL L. KLEIN, JAMES C. FOLK, SAMUEL G. FARMER, RICHARD S. MUNSEN, ROBERT J. CHAMPFER, K R. SLETTEN, LONG-TERM JUXTAFOVEAL RETINAL TELANGIECTASIA Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 25, pp. 727- 735 ,(2005) , 10.1097/00006982-200509000-00007
Subrata Mandal, Pradeep Venkatesh, Zahir Abbas, Rajpal Vohra, Satpal Garg, Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 1825- 1829 ,(2007) , 10.1007/S00417-007-0567-8
Lazaros Konstantinidis, Irmela Mantel, Leonidas Zografos, Aude Ambresin, Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 247, pp. 1567- 1569 ,(2009) , 10.1007/S00417-009-1117-3
S. N. Cox, E. Hay, A. C. Bird, Treatment of Chronic Macular Edema With Acetazolamide Archives of Ophthalmology. ,vol. 106, pp. 1190- 1195 ,(1988) , 10.1001/ARCHOPHT.1988.01060140350030